Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Maria Palasis currently holds 12,432 shares of Lyra Therapeutics, Inc. (LYRA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Maria Palasis has been a net seller of LYRA stock. They have purchased $0 and sold $99.1K worth of shares.
Maria Palasis's most recent insider trade was on Jan 13, 2026, when they sold 3,997 shares at $0.00 per share.
Maria Palasis serves as Executive at Lyra Therapeutics, Inc. (LYRA). They have executed 9 insider transactions totaling $99.1K over their tenure at the company.
Maria Palasis holds the position of Executive at Lyra Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 2 years and currently hold a stake valued at $0.
Maria Palasis has shown a selling trading pattern, with $0 in total purchases and $99.1K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Maria Palasis was on Oct 31, 2025, when they sold $34.6K worth of BBNX shares. This transaction involved 1,287 shares at $26.86 per share.
Maria Palasis currently owns 12,432 shares of Lyra Therapeutics, Inc. (LYRA), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Maria Palasis's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Maria Palasis has 9 Form 4 filings on record as an insider at Lyra Therapeutics, Inc..
Set alerts for Maria Palasis and 40,000+ other insiders.